Biosimilar medicine fact sheet – infliximab
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
- Inflectra® was listed on the PBS on 1 December 2015.
- Renflexis® was listed on the PBS on 1 August 2017.
These brands are listed under the Section 100 Highly Specialised Drugs Program.